Identification of Complex Small Molecules
Case Details
Start Day: 12/09/2024
Clients: Large Generics Company
Tags: Complex Small Molecules, Patent Expiry Analysis, Us Patent Expiry, Eu Patent Expiry, Generic Opportunity Assessment, Generic Pipeline Strategy, Market Evaluation, Small Molecule Profiling, Biopharma Strategy, Generic Drug Development, Cagr Projection, Pharmaceutical Intelligence, Competitive Landscape, Patent Cliffs, Generic Launch Planning, Molecule Complexity Scoring, Pharma Analytics, Us Eu Markets, Drug Opportunity Assessment, Lifecycle Management
Project Duration: 12 Months
Let’s Work Together for Development
Call us directly, submit a sample or email us!
The Story
Identification of complex small molecules based on US & EU patent expiry
Identified and analyzed complex small molecules in the US and EU markets based on patent expiration, profiled 60 products, and recommended 50 for generic development due to favorable sales growth projections and strategic criteria.
What Did Octavus Do
Using the criteria for patent expiration in the US and EU, a number of small molecules were identified with varying complexity levels showing promising sales growth projections according to CAGR calculations until 2025.
Data Analysis Chart
The Results
Octavus proposed these solutions based on the research conducted for Client.
